CRYAB and osteosarcoma: In clear cell and papillary type renal cell carcinoma and colorectal cancer, CRYAB is used as a marker for higher tumor stage and distant metastases, and in osteosarcoma, it is a marker for increased metastases and poor chemotherapy response [4].